|
Health Program
2004 Prescription Drug State Legislation
Data complete for 2004; revised and reposted: November 2006
For 2004, state legislatures again grappled with a wide variety of bills affecting pharmaceuticals.1 Recent reports indicate that the double-digit annual cost increases of 13 to 18 percent in 2002 have moderated to below 10 percent for some segments of the purchasing market this year.2 The number of states with enacted or operational pharmaceutical assistance programs reached a new high of 39 states as of May 2004, prior to the start of the federal Medicare discount program. Despite numerous past year actions, more than 320 bills and resolutions were filed for 2004 sessions. Many of these measures address discount or subsidy programs, as well as other access, disclosure and cost containment strategies. Pharmaceutical bills were filed in 43 out of the 44 states that held sessions in 2004. Six states had no regular session in 2004.
|
Among new trends for 2004 are at least 62 bills and resolutions seeking to adjust state programs in response to the federal Medicare Prescription Drug Improvement, and Modernization Act of 2003 (P.L.108-173). Also, 27 states addressed state importation of prescription drugs. |
 |
In 2004,almost half the states had measures aimed at providing pharmaceutical discounts. About a dozen states each considered programs to allow or regulate reuse of unused drugs from nursing homes and similar facilities, sought to regulate pharmacy benefit managers (PBMs) or disclose marketing costs. Eight states examined expanded use of the federal 340B drug discount program, while 14 discussed bulk or coordinated purchasing. In October, New Jersey became the first state to tackle flu vaccine rationing and pricing.
2004 LAWS: By the end of all 2004 sessions, bills were signed or became law in 25 states: Alaska, California (5), Connecticut (2), the District of Columbia, Florida, Hawaii (4), Illinois, Indiana (2), Louisiana, Maine (4), Maryland, Massachusetts (2), Missouri, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Rhode Island (7), South Dakota (3), Tennessee, Vermont, Virginia (2), West Virginia (2), Wisconsin, and Wyoming.
Non-binding resolutions were finally passed in California (4), Hawaii (4), Massachusetts, Rhode Island (2), Vermont and Wisconsin. Measures that only affected existing Medicaid programs generally were not tracked in this report. See NCSL's
Recent Medicaid Prescription Drug Laws and Strategies for examples of Medicaid changes.
TABLE #1B - 2004 Prescription Drug Legislation by Topic
| Prescription Drug Bill Topic |
Topic
Code |
States with 2004 legislation
(Underline = passed) |
| Use of federal 340B discount price program |
340B |
CA, CO, CT, KY, MN, NM, VT, VA |
| Multi-state or agency bulk purchase |
Bulk |
AL, CA, CO, CT, DC, HI, IN, MA, MN, MS, NE, NH, NY, VT, WV |
| Clearinghouse information |
CL |
CO, GA, HI, IL, IA, MA, MS, TN, VA, WV, WI |
| Discount program & price-related policy |
D |
AL, AK, CA, CO, DE, DC, FL, GA, HI, ID, IN, IA, LA, ME, MA, MN, MS, NH, NJ, NM, NY, OH, OK, RI, VT, VA, WA, WV |
| Relates to generic drugs |
Generic |
AL, FL, HI, IN, NH, RI, UT, VT |
| Regulate drug importation or reimportation |
Imp |
AZ, CA, CT, DC, FL, HI, ID, IL, KY, LA, MD, MN, MO, MS, NE, NH, NY, PA, RI, TN, VT, VA, WA, WV, WI |
| Regulate prescriptions, labels or packaging on retail pharmaceuticals |
Lab |
CA, IL, IN, LA, MD, MI, MN, NY, TN, WI |
| Relates to mail-order of pharmaceuticals |
Mail |
CO, GA, IA, ME, MD, MA, MI, NJ, NY, TN, VT |
| Marketing & advertising |
Mkt |
AK, CA, DC, HI, IL, KY, MD, MN, MS, NY, RI, VT, WV
Also see separate NCSL Report at rxads.htm |
Medicaid
(partial list; see notes) |
M |
AL, CA, CO, DC, ID, ME, MA, MN, MS, NH, NJ, NM, NC, RI, TN, VT, WV, WY
See separate NCSL report at medicaidrx.htm |
| Medicare Prescription Drug Act of 2003 (MMA), state adjustments & changes |
MMA |
AK, CA, CT, FL, HI, IL, IN, IA, ME, MD, MA, MN, MO, NJ, NY, NC, PA, RI, SD, TN, UT, VT, VA, WV, WY
See separate NCSL Medicare Rx report [pdf] |
| Pharmacy Plus waivers from Medicaid |
P+ |
CO, FL, WY |
| Regulation of pharmaceutical benefit managers |
PBM |
CA, CT, DC, FL, IL, IA, ME, MD, MI, MN, MS, NH, NY, SD, VT |
Preferred Drug List
(partial list; see notes) |
PDL |
CA, CO, CT, FL, HI, ME, MA, NH, VT, WV, WY |
| Relates to pricing of pharmaceuticals |
Price |
GA, HI, ME, NJ, NM, NY, OH, OK, RI, VT, WV, WI |
| Reuse or recycling of pharmaceuticals |
Re |
HI, IN, IA, KY, LA, ME, MO, NE, NM, OK, SD, WI |
| State Rx Subsidy program |
S |
AK, CT, DE, DC, FL, HI, KY, ME, MA, MI, MN, MO, NJ, NY, NC, PA, RI, TN, UT, VT, VA, WV, WI, WY |
| Study or task force on Rx |
Study |
AZ, CA, GA, IN, LA, MA, NH, NJ, NY, VA, VT, WV, WY |
| Other Rx policy |
- |
AL, CA, HI, ID, IA, KS, KY, LA, MD, MI, MS, NE, NJ, NM, NY, VA, WV, WI |
Summary Table notes: Bill content and functions may vary widely. Not all topics are categorized in Table #1B. Please use the state Table #2B and bill links below for all details. Bills initially filed in 2003 are summarized on a separate 2003 Table #1A.
2003 legislation, including 82 bills and resolutions signed into law, are available online in the NCSL Report: 2003 State Prescription Drug State Legislation.
TABLE #2B - 2004 Prescription Drug Legislation by State
State/bill/ web link / sponsor
yellow background = enacted or completed |
Description / excerpts of bill text
Only includes prescription drug bills newly filed for the 2004 state legislative sessions. Bill status may change frequently - check state legislative links below or legislative offices for the most recent actions. |
Topic
code |
AL
HB 156
Rep. Johnson
 |
Would levy the privilege tax on each prescription filled or refilled regardless of whether the prescription was filled for a citizen of Alabama.
(Filed 2/3/04; did not pass by end of session 5/04)| |
Tax, - |
AL
HB 747
|
Would create the Alabama Prescription Cost Initiative and Board; with authority to negotiate for drug discounts, rebates or cooperatives.
(Filed 4/6/04; favorable committee substitute 4/14/04; no additional action before end of session 5/17/04)| |
Bulk, D, M |
AL
SB 193
Sen. Smitherman
|
Would require a physician prescribing a medication to prescribe a generic equivalent if available unless the physician notes in the patient's record that the brand name is medically necessary and notes on the prescription to the pharmacist that the brand name medication is medically necessary.
(Filed 2/3/04 and sent to committee; no additional action before end of session 5/17/04)| |
Generic - |
AK
HB 328
Rep. Gara |
Would allow a pharmacy to advertise that the pharmacy offers a senior prescription drug discount plan under certain conditions. "A pharmacy may participate in the Alaska senior prescription drug discount plan, In order to advertise that the pharmacy is part of the plan, a pharmacy, upon presentation of a valid prescription for a prescribed drug covered under the program and the patient's Medicare card, may not charge a Medicare patient a price for the prescribed drug that exceeds the drug reimbursement rate set by the state for the Medicaid program.
(Filed 5/20/03; no additional action before end of session)| |
MMA, Mkt |
AK
SB 259
Finance Comm.
|
Would establish the SeniorCare program, that would provide cash assistance and prescription drug benefits as specified as far as practicable under appropriations provided by law. Eligibility: Age 65 or older, not more than 135 percent of the federal poverty level for this state to be eligible for cash assistance under this section or prescription drug benefits; or of more than 135 percent, but not more than 150 percent, of the federal poverty level for this state for prescription drug benefits.
(Filed and sent to committee 1/12/2004; no additional action before end of session)| |
S |
AK
HB 374,
SB 259
Governor
|
Would create two pharmaceutical assistance programs. 1) $120-per-month cash assistance option or a new $1,600-per-year prescription drug plan that would end when the Medicare benefit goes into effect January 2006. Eligibility for 65 and older with incomes of less than $15,134 a year and liquid assets of less than $4,000. Couple maximum combined income of $20,439 and liquid assets of up to $6,000. 2) An optional reimbursement benefit of $1,000 a year would be available for those up to 150 percent of the federal poverty level, or $16,815 a year for a single person and $22,710 for a couple. Effective date and operational for beneficiaries, April 2004.
Update: The SeniorCare Rx program is being coordinated with the Medicare $600 transitional subsidy, for a benefit described as totaling $2200 per year.
(HB 374 Passed House 2/4/04; Passed Senate 2/19/04; signed by governor as Act 3, 3/5/04)| |
D, MMA, S |
AZ
HM 2001
Rep. McClure
|
Non-binding resolution would urge the United States Department of Health and Human Services to certify the safety of Canadian drugs for importation.
(Filed 1/14 and sent to committees 1/27/04; failed to pass 2/12/04)| |
Imp |
AZ
H 2555
Rep. Jayne
|
Would establish a prescription drug price information study committee.
(Filed 1/29/04; did not pass by end of regular session)| |
Study |
| AR |
Arkansas has no regular 2004 session |
|
CA
AB 262
Assm. Chan |
Would prohibit the sale of patient information from Rx purchases.
(Filed 2/4/03; passed Assembly 1/6/04; amended & passed Senate 22y-15n, 8/25/04; did not pass by end of regular session 8/31/04) |
- |
CA
AB 1957
Assm. Frommer
|
Requires the State Board of Pharmacy to establish a Web site on or before July 1, 2005, to facilitate the safe purchase by California residents of prescription drugs at reduced prices. Would require the Web site to include price comparisons of prescription drugs, including prices charged by licensed pharmacies in the state and Canadian pharmacies that provide mail order service to the United States that meet certification requirements.
(Favorable committee reports; passed Assembly 5/26/04; passed Senate 21y-13n, 8/26/04; vetoed by governor 9/29/04) | |
Imp, M |
CA
AB 1958
Assm. Frommer
|
Authorizes the Public Employees' Retirement System (for state and public employees health benefits) to establish or enter into pharmaceutical purchasing consortiums with private or public entities, including other states.
(Filed 2/12/04; passed Assembly 5/26/04; passed Senate 21y-11n, 8/26/04; vetoed by governor 9/29/04) | |
Bulk |
CA
AB 1959
Assm. Chu
|
Requires the State Auditor to conduct audits of the state's prescription drug procurement and reimbursement practices. The audit report shall include:
(1) A review of a representative sample of the state's procurement and reimbursement of drugs "to determine whether the state is receiving the best value for the drugs it purchases."
(2) A comparison of drug costs to the state with drug costs to other appropriate entities such as the federal government, the Canadian government, and private payers.
(3) A determination of whether the state's procurement and reimbursement practices result in savings from strategies such as negotiated discounts, rebates, and contracts with multistate
purchasing organizations, and whether the strategies selected by the state result in the lowest possible costs. A first report is due May 31, 2005.
(Original language, deleted from final version) Would have authorized the chair and vice chair of specified committees of the Legislature to inspect any state agency contracts for single-source or multiple-source drugs or health benefit plans for employees (including confidential rebate contracts), and required such legislators to maintain the confidentiality of the contracts or amendments to the contract.
(Filed 2/12/04; passed Assembly 5/26/04; passed Senate; signed by governor as Chapter 938, 9/29/04) |
Study
Bulk, D, M, price
|
CA
AB 1960
Assm. Pavley
|
Defines the term "pharmacy benefits management" (PBM) as negotiating the purchase of dangerous drugs on behalf of specified entities and administering or managing the prescription drug benefit programs of those entities and as an entity that performs pharmacy benefits management. Would also impose on that entity a fiduciary duty to the person employing or contracting with the entity.
(Filed 2/12/04; passed Assembly 5/26/04; passed Senate 23y-19n, 8/25/04; vetoed by governor 9/29/04) | |
PBM |
CA
AB 2125
Assm. Levine
|
Would require physicians to indicate the patient's diagnosis on each prescription and require the pharmacist to add it to the label unless directed otherwise by the patient.
(Filed 2/18/04, died; did not pass committee 4/20/04, 8/31/04) | |
Lab |
CA
AB 2151
Assm. Jackson
|
Medi-Cal Reimbursement Rates: Allows a community clinic or free clinic that has a licensed drug dispensary to bill Medi-Cal or Family PACT for drugs purchased through the federal 340B program at the clinic's acquisition cost plus a dispensing fee of up to twelve dollars ($12), or its usual charge made to the general public, whichever is less.
(Filed; passed Assembly and Senate; signed by governor as Chapter 851 of Statutes 2004, 9/29/04). |
340B, M |
CA
AB 2326
Assm. Corbett
|
Would support the establishment by the state of an evidence-based prescription drug program for health care consumers and purchasers that identifies preferred drugs and increases public awareness regarding the safe and cost-effective use of drugs.
(Filed 2/12/04; passed Assembly 5/26/04; died; did not pass Senate committee 8/17/04) |
PDL |
CA
AB 2682
Assm. McLeod
|
Requires the state Board of Pharmacy to adopt regulations governing any person engaged in the wholesale distribution of prescription drugs, which regulations shall implement the same federal regulatory provisions applicable to wholesalers engaged in interstate commerce. Requires all out-of-state wholesalers selling or distributing prescription drugs or devices in California to obtain an out-of-state dangerous drugs and devices distributor's license from the board.
(Filed 2/20/04; passed Assembly 5/18/04; passed Senate 21y-14n, 8/27/04; signed by governor as Chapter 938, 9/29/04) |
wholesale |
CA
AJR. 61
Assm. Ridley |
Non-binding resolution requests the U.S. Secretary of Health and Human Services to certify to Congress that implementation of provisions of the Medicare Prescription Drug, Improvement and Modernization Act of 2003, permitting the importation of prescription drugs from Canada into the United States will pose no additional risk to the public's health and safety.
(Adopted in Assembly 46y-24n, 4/22/04; adopted in Senate 22y-13n, 7/1/04; chaptered by Secretary of State as Resolution Chapter 111, 7/8/04) |
Imp, MMA |
CA
AJR 62
Assm. Ridley
|
Non-binding resolution urges Congress to repeal Medicare law prohibitions on federal government negotiating fair prices, and requests members of the state delegation to" sponsor and support legislation to repeal" such language.
(Adopted in Assembly 45y-26n 4/22/04; adopted in Senate 22y-12n, 7/1/04; chaptered by Secretary of State as Resolution Chapter 112, 7/8/04) |
MMA |
CA
SB 1144
Sen. Pres. Burton
|
Provides that the state General Services Department can purchase pharmaceuticals from authorized Canadian pharmacies or sources, as well as existing in-state sources, for use with state hospitals and prisons. Adds Canada to a required progress report on bulk and discount purchasing due by 2/1/05.
(Favorable report; passed Senate 23y-12n, 5/24/04; passed Assembly 51y-25n, 8/25/04; vetoed by governor 9/29/04; sent to S. unfinished business 10/4/04) |
Imp, Bulk |
CA
SB 1149
Sen. Ortiz
|
Requires the Board of Pharmacy to collect and publish information concerning suppliers of dangerous drugs that are located and operating outside of the United States that have violated safe shipment, handling, and processing standards.
(Favorable committee report; passed Senate 24y-13n, 6/23/04; passed Assembly 8/27/04; vetoed by governor 9/29/04; sent to S. unfinished business 10/4/04) |
Imp |
CA
SB 1333
Sen. Perata
|
Authorizes the Department of Health Services to reimburse a pharmacy that provides to a Medi-Cal or AIDS Drug Assistance Program (ADAP) beneficiary a prescription drug that was purchased from a Canadian pharmacy. Provides the formula for determination of such reimbursement.
(Filed 2/18/04; passed Senate 24y-9n; passed Assembly 8/26/04; vetoed by governor 9/29/04; sent to S. unfinished business 10/4/04) |
Imp, M |
CA
SB 1426
Sen. Ducheny
|
Requires the department to adopt policies and procedures for drug utilization that will optimize efficacy and cost-efficiency within the correctional system, in coordination with the Department of General Services' prescription drug bulk purchasing program, and to adopt best practices standards for pharmaceuticals established by recognized professional health care organizations, as specified.
(Filed 2/19/04; passed Senate 35y0n, 5/3/04; passed Assembly 77y-0n, 8/12/04; became law as Chapter 383 of 2004, 8/30/04) | |
Bulk, Study |
CA
SB 1427
Sen. Ackerman
|
Would enact that any person who initially introduces into commerce a drug that is counterfeit is guilty of a felony, punishable by imprisonment in the state prison, if that action results in the death of a human being.
(Filed 2/16/04; did not pass committee 3/4/04; died 8/31/04) | |
Counterfeit |
CA
SB 1765
Sen. Sher
|
Requires pharmaceutical companies to adopt a Comprehensive Compliance Program that is in accordance with a related federal government publication, to include policies on marketing interactions with health care professionals and limits on gifts and incentives to medical or health professionals, incluing "specific annual dollar limit on gifts, promotional materials, or items or activities that the pharmaceutical company may give or otherwise provide to an individual
medical or health care professional. '
(Initial language, deleted from final bill) Would prohibit a pharmaceutical or drug manufacturer from giving gifts to medical or health professionals, with exceptions for drug samples, educational materials, low-cost items primarily associated with a health care professional's practice, and up to 4 meals per year.
(Filed 2/20/04; passed Senate 21y-14n, 4/22/04; amended & passed Assembly 8/23/04; signed by governor as Chapter 927, 9/29/04) | |
Mkt |
CA
SB 1913
Committee on Business and Professions
|
Prohibits a manufacturer of pharmaceuticals from operating without employing sufficient, qualified supervision to adequately safeguard and protect the public health. Other provisions affect pharmacist practices and personnel.
(Filed 3/17/04; passed Senate 5/27/04; amended and passed Assembly 8/23/04; signed by governor as Chapter 695, 9/22/04) |
- |
CA
SJR 24
Sen. Ortiz
|
Requests or memorializes the President and U.S. Congress to recognize the problems caused by direct-to-consumer advertising of prescription drugs by pharmaceutical companies and to take specified actions in the regulation of consumer advertising of prescription drugs.
(Filed 2/25/04; adopted by Senate 3/30/04; amended and adopted by Assembly 49y-25n, 7/1/04; chaptered by Secretary of State as Resolution Chapter 139 of 2004, 8/12/04) |
Mkt |
CA
SJR 25
Sen. Ortiz
|
Non-binding resolution, requests the U.S. Congress and the President to enact and sign into law specified revisions to the Medicare Prescription Drug Improvement and Modernization Act of 2003 including: Index increases in beneficiaries' premiums, deductibles, and cost sharing limits to increases in Social Security benefits or changes in income for beneficiaries; give authority to the Secretary of the United States Department of Health and Human Services to negotiate the prices of drugs to be made available to beneficiaries under the Act; to direct the Secretary to work with states on establishing workable systems to enable beneficiaries and others to safely import drugs from Canada; to allow states to receive matching funds if they choose to maintain the existing level of drug coverage for beneficiaries who are dually eligible for Medicare and Medicaid
(Filed 3/8/04; adopted by Senate 3/30/04; adopted by Assembly 47y-28n, 8/18/04; chaptered by Secretary of State as Resolution Chapter 168, 9/1/04) |
Imp,
MMA |
CO
SB 92
Tapia
|
Would establish the Colorado Prescription Drug Discount Program to provide a prescription drug discount to eligible persons at a rate similar to the Medicaid rate, or not more than 10percent above that rate. Would specify eligibility as residents with income up to 200percent of federal poverty not eligible for Medicaid. Would require the program to charge an annual program enrollment fee of $25. Would specify that implementation requires receipt of federal approval, with an application to be prepared only if the state receives gifts, grants, or donations sufficient to provide for the state's administrative costs of submitting the application for federal approval.
(Filed 1/12/04; died in committee at end of regular session 5/5/04)| |
D, M, P+ |
CO
SB 184
Rep. S. Johnson
|
Would create a preferred drug list for Medicaid.
(Filed 1/13/04; died in committee at end of regular session 5/5/04)| |
M, PDL |
CO
HB 1128
Rep. Salazar
|
Would establish the Colorado bulk purchasing council, with all state agencies authorized to participate.
(Filed 1/13/04; died in committee at end of regular session 5/5/04)| |
Bulk |
CO
HB 1238
Rep. McFadyen
|
Would address access to maintenance drugs from prescription drug outlets for covered persons. Makes it an unfair method of competition and unfair or deceptive act or practice in the business of insurance to refuse to reimburse a retail prescription drug outlet, differentiate between mail order and retail prescription drug outlets, or otherwise restrict or limit such outlets in violation of the law.
(Filed 1/28/04; died in committee at end of regular session 5/5/04)| |
Mail |
CO
HB 1268
Rep. Pommer
|
Would create a Colorado Rx clearinghouse to provide residents with access through the free and discount patient assistance programs sponsored by pharmaceutical drug companies. The state could charge a fee for such services, but would not purchase drugs for residents.
(Filed 1/28/04; died in committee 2/12/04)| |
CL |
CO
HJR 1070
Rep. Frangas
|
Would encourage all health care facilities that may qualify as covered entities under the federal 340B drug pricing program to maximize the utilization of the program, and have all state agencies explore all avenues with 340B "to receive maximum state budget savings."
(Filed and sent to committee 4/15/04; no further action before end of session 5/5/04)| |
340B |
CT
HB 5008
Comm. on Aging
|
Provides for replacement prescriptions if dispensed products are lost by or stolen from a ConnPACE enrollee; requires an affidavit describing circumstances; and allows copayments to be waived.
(Filed 2/4/04 passed House and Senate 4/28/04; signed by governor as Act 04-104, 5/21/04)
|
S |
CT
HB 5026, 5027, 5029, 5085, 5088, 5093, 5192, 5195, 5282, 5283, 5284, 5336
SB 2, 5, 9, 13, 15, 24, 89, 90, 199, 200
|
Would change various parts of the ConnPACE pharmaceutical subsidy program including: elimination or change of the estate recovery provision enacted in 2003, allow for replacement prescriptions, change the asset test, change cost sharing, change supply limits for maintenance drugs, and others.
(Filed 1/04; did not pass by end of regular session 5/5/04)| |
S |
CT
HB 5040
Gov. Budget/Rep. Ward
|
Would direct federally qualified health centers (FQHCs) to enroll in 340B, but the language was stricken from an amended version.
(Filed 2/04; Rx language deleted and did not pass) |
340B |
CT
HB 5617
Human Services Committee
|
Would add a health care and pharmaceutical component to the state's general assistance program through federally qualified health centers.
(Filed 3/3/04; did not pass by end of regular session 5/5/04)| |
S, 340B |
CT
SB 8
Rep. Bruce Zalaski
|
Would require the CT Commissioner of Social Services to establish a procedure by which ConnPACE participants may obtain covered prescription drugs from Canadian pharmacies and waive the copayment charge for such drugs. Also addresses Medicare coordination of benefits and auto enrollment.
(Filed and sent to committee, 2/4/04; passed Senate 4/21/04; passed House 4/22/04; signed by governor 4/28/04 as Public Act 04-101) |
Imp, MMA, S |
CT
SB 111
|
Would regulate pharmacy benefit management companies, requiring an annual license from the Insurance Commission, a license to practice pharmacy, financial statements, approval of contracts, and cannot discriminate when contracting with pharmacies on the basis of copayments or days of supply.
(Filed 2/11/04; passed Senate 4/22/04; did not pass by end of regular session 5/5/04)| |
PBM |
CT
SB 295
Program Review and Investigations Committee
|
Would make changes to the state's preferred drug list process for Medicaid and ConnPACE.
(Filed 2/18/04; did not pass by end of regular session 5/5/04)| |
PDL, S |
CT
SB 351
Public Health Committee
|
Would require the development of a comprehensive preferred drug list, rather than one limited to three classes of drugs.
(Filed 2/19/04; did not pass by end of regular session 5/5/04)| |
PDL |
CT
SB 472
Public Health Committee
|
Would develop a plan for unified prescription purchasing for all state purchases through the University of Connecticut Health Center, an expanded preferred drug list and the purchase of state-funded prescription drugs from other jurisdictions.
(Filed 2/25/04; did not pass by end of regular session 5/5/04)| |
PDL, bulk, Imp, 340B |
CT
SB 609
Appropriations Committee
|
Would seek to maximize the amount of federal funding for which the state is eligible under new provisions of federal law related to Medicare, Medicaid, DSH payments and employer- sponsored retirement plans providing prescription benefits.
(Filed 3/11/04; did not pass by end of regular session 5/5/04)| |
MMA |
DE
SB 320
Sen. Cook
|
FY05 Budget (Sec. 162) requires an Rx manufacturers' rebate program for all non-Medicaid state pharmaceutical programs, based on the full Medicaid rebate structure. Appropriates $6.9 million for the senior pharmaceutical Assistance Program, funded with Tobacco Settlement funds.
(Passed Senate 6/22/04; passed House 6/30/04) |
D, S |
DC
B15-569
Councilmember Catania
|
Enacts the Rx Access Act of 2003, requiring the Dept. of Health to run an AccessRx subsidy program for low-income elderly District residents (eligibility: age 62 or older with household income not more than 200 percent of federal poverty), with enrollees to pay 20 percent of the cost of prescriptions. Also establishes discount prices for qualified uninsured residents (eligibility: any District resident with household income not more than 350 percent of federal poverty, not enrolled in any insurance program) . Requires drug manufacturers to enter into rebate agreements for products sold to publicly funded programs, with public disclosure and possible prior authorization restrictions for products lacking rebate agreements. Includes requirements for disclosure and reporting of Rx marketing costs by manufacturers; also permits negotiations with other states or jurisdictions for bulk purchasing. Also provides that the Department "shall investigate purchases from outside the U.S. Also regulates PBMs, including establishing a legal "fiduciary duty" to any covered entity or customer, transparent business practices, pass through of payments and disclosure of rebates from manufacturers.
(Filed 11/4/03; Passed City Council 3/24/04; signed by mayor as Act 15-410) |
This law is being challenged in court in a case named "Biotechnology Industry Organization and Pharmaceutical Research and Manufacturers of America v. District of Columbia, U.S. Court of Appeals for the Federal Circuit No. 2006-1593" it was pending as of 11/06. 18 consumer groups filed an amici brief on 11/6/06)  |
Bulk, D, Imp, M, Mkt, PBM, S |
FL
HB 541
Rep. Justice
|
Non-binding memorial, would urge the Congress of the United States to support the Medicare Prescription Drug Savings Act of 2003 to allow direct negotiation of prescription drug prices with pharmaceutical companies.
(Filed 1/20/04; died in committee 4/30/04)| |
MMA |
FL
HB 1347
S 3042
Rep. Roberson
|
Would define role and responsibilities of PBMs and would allow for dispensation and purchase of Canadian prescription medicines if federally approved.
(Filed 2/25/04; died in committee 4/30/04)| |
PBM, Imp |
FL
HB 1837 |
Appropriations
|
Budget bill provides that 1) if the federal Centers for Medicare and Medicaid approve LifeSaver Rx subsidy program waiver during the 2004-05 year, the program may apply to increase the state share of spending to cover persons with higher incomes.
2) Section 110.12315 establishes a redefined State Employees Prescription drug program, with increased copays, from $10 to $80, and required use of a preferred drug list (PDL)
(Filed 3/28/04; passed House 4/1/04; passed Senate 4/2/04; signed by governor as Chapter 2004-269, 5/28/04)| |
copay, PDL, S, P+ |
FL
HB 1843 |
Appropriations
|
Budget bill reauthorizes the FL Lifesaver Rx program, "in the absense of federal approval from CMS," to provide benefits to residents up to 120 percent of federal poverty, with subsidies up to $160 per month. The program is to apply "cost controls applied to other Medicaid prescribed drug benefits" and to include copayments of $2 for generics, $5 for products on hte preferred drug list (PDL) and $15 for non-PDL drugs.
(Filed 3/04; passed House and Senate, 5/04; signed by governor as Chapter 2004-270, 5/28/04)| |
PDL, P+, S |
FL
SB 2542
Sen. Siplin
|
Would allow patients to participate in health care decisions, select their physician or other health care provider, and choose between generic or brand-name prescription medications.
(Filed 3/2/04; died in committee 4/30/04)| |
Generic |
GA
HB 935
Rep. Harrell
|
Would create an advisory group on seniors and prescription drug costs.
(Filed 4/8/03, passed House 3/15/04; did not pass by end of regular session 4/04)| |
Study |
GA
HB 1061
Rep. Stephens
HB 1220
Rep. Stephens
|
Would provide a process schedule of maximum manufacturer prices for patented prescription drugs and certain other drugs sold in the state
(Filed 1/5/04; did not pass by end of regular session 4/04)| |
D, Price |
GA
HB 1442
Rep. Gardner
|
Would require pharmacist to ensure that the total pharmacy reimbursement cost of a prescription drug is printed on the receipt that the patient receives upon the purchase of such prescription drug dispensed.
(Filed 2/12/04; Committee reported favorably 2/25/04; did not pass by end of regular session 4/04)| |
D, Price |
GA
HB 1478
Rep. Dodson
|
Would permit a health maintenance organization to utilize a licensed Georgia pharmacy that is owned and operated by such health maintenance organization to distribute refills of prescription drugs by mail or other common carrier for its enrollees only.
(Filed 2/16/04; did not pass by end of regular session 4/04)| |
Mail |
GA
HB 1692
Rep. Hill
|
Would establish a drug repository program to accept and dispense donated prescription drugs.
(Filed 3/4/04; did not pass by end of regular session 4/04)| |
CL |
GA
SB 543
Sen. Balfour
|
Among other things, would allow a pharmacist to use mail order to fill prescriptions for customers.
(Filed 2/20/04; did not pass by end of regular session 4/04)| |
Mail |
GA
SB 544
Sen. Balfour
|
Would allow health maintenance organizations to utilize Georgia based pharmacies to provide mail order prescription services to its members.
(Filed 2/20/04; did not pass by end of regular session 4/04)| |
Mail |
HI
HB 1920
Rep. Takumi
|
Would establish ethical marketing requirement for prescription drugs. Requires manufacturers and labelers who sell prescription drugs in Hawaii to disclose the value, nature, and purpose of gifts and other economic benefits given doctors and other health care providers in connection with detailing, marketing, or promotions.
(Filed 1/23/04; died at end of regular session 5/5/04)| |
Mkt |
HI
HB 1921
Rep. Takumi
|
Would direct the governor and agencies to develop, operate, and maintain a website to assist Hawaii residents in purchasing prescription drugs from Canada.
(Filed 1/23/04; died at end of regular session 5/5/04)| |
Imp. |
HI
HB 2005 final
Rep. Say
|
Establishes a prescription drug return and reuse program, and authorizes donated drug repositories. Authorizes pharmacists to receive and redistribute previously dispensed drugs under regulated circumstances.
[House version; deleted in signed version] Would change the name of the Rx program to Rx plus; adds new definitions of "covered drugs", "participating retail pharmacy", and "qualified resident"; establishes requirements to determine qualified residents; requires department of human services to conduct ongoing quality assurance activities; clarifies consequences applicable to nonparticipating manufacturers. (The program is scheduled to be operational July 1, 2004- see SB 3237 below for final discount law)
(Filed 1/23/04; passed House 3/2/04; passed Senate 4/13; signed by governor as Act 190, 7/9/04 |
D, MMA, Re |
HI
SB 2090
Sen. Baker
|
Would establish the prescription drug repository program to receive and dispense donated prescription drugs to needy persons.
(Filed 1/21/04; passed Senate 3/9/04; died in House 5/5/04)| |
Re |
HI
HB 2096
Rep. Arakaki
|
Would establish the prescription drug repository program to receive and dispense donated prescription drugs to needy persons.
(Filed 1/23/04; ; died at end of regular session 5/5/04)| |
Re |
HI
HB 2161
Rep. Schatz
|
Would establish a refundable income tax credit of 10 percent of the cost of prescription drugs for residents whose income is 200 percent of the federal poverty level or less.
(Filed 1/26/04; ; died at end of regular session 5/5/04)| |
S |
HI
HB 2460
Rep. Say
SB 2935
Sen. Bunda
|
Would amend the Hawaii Rx program based on the U.S. Supreme Court's ruling on the Maine Rx program on which Hawaii Rx is modeled, to: (1) address the concerns of the Centers for Medicare and Medicaid Services to protect access of Medicaid clients to the prescription drugs they need; (2) prevent loss of prescription of drug benefits to employees covered by employer-sponsored drug benefit plans; (3) address the concerns of pharmacies and drug manufacturers; (4) adjust the manufacturers' the rebate; and (5) rename the program Hawaii Rx Plus.
(Filed 1/26/04; died at end of regular session 5/5/04)| |
D, MMA |
HI
HB 2475,
SB 2950
|
Makes U.S. FDA-approved, therapeutically equivalent generic drug products substitutable upon approval by the director of health.
(SB 2950 filed 1/26/04; passed Senate 3/9/04; passed House 4/8/04; signed by governor as Act 24, 4/29/04)| |
Generic |
HI
HB 2707
Rep. Oshiro
|
Would establish the Prescription Drug Cost Containment Program to reduce the costs of prescription drugs for Hawaii residents, while maintaining high quality in prescription drug therapies.
(Filed 1/27/04; died at end of regular session 5/5/04)| |
PDL, CL, Bulk |
HI
HB 2987
Rep. Hiraki
|
Would adopt income limits and other eligibility requirements for state drug prescription program. Clarifies consequences of manufacturer nonparticipation. Requires rebates from participating manufacturers. Establishes committee to recommend drugs for preferred and nonpreferred drug lists.
(Filed 1/28/04; died at end of regular session 5/5/04)| |
D, Rebate, PDL |
HI
HR 54
HCR 81
Rep. Say
|
Non-binding resolutions, would urge members of Congress to "to promote the repeal of the Medicare Modernization Act and work to enact legislation that will ensure universal access to a single-payer uniform health insurance program with subsidies for needy seniors and establish a prescription drug plan as part of the traditional Medicare program designed to lower the cost of prescription drugs for everyone through bulk purchasing" or to work for reform of high premiums and restricted asset tests.
(HR 54 adopted by House 4/13/04;
HCR 81 passed House; did not pass Senate 5/5/04) |
MMA |
HI
SR 24,
HR80,
SCR 56
Sen. Menor
|
Non-binding resolution, would urge the president and congress to repeal the ban against federal negotiating of price reductions for prescription drugs.
(SR 24- Filed 3/15/04; resolution adopted by Senate 4/8/04; sent to Congress 4/30/04)|
(SCR56 adopted by Senate 4/8/04; adopted by House 4/29/04; sent to Congress 5/10/04)| |
MMA |
HI
SB 2648
Sen. Chun
|
Would require the department of human services to enter into prescription drug purchasing alliances with other states and other public and private entities.
(Filed 1/26/04; died at end of regular session 5/5/04)| |
Bulk |
HI
HCR 70, HCR 80, HCR 192, HR 134, SCR 125, SR 63
|
Non-binding resolutions generally would urge the Congress and President to allow prescription drugs to be imported from Canada.
(Filed 1/04; died at end of regular session 5/5/04 |
Imp |
HI
SB 2684
Sen. Hooser
|
Would authorize the Department of Public Safety to purchase from Canada maintenance prescription drugs equivalent to FDA-approved drugs for its inmate population.
(Filed 1/26/04; died at end of regular session 5/5/04)| |
Imp |
HI
HR 47,
HCR 70,
SCR 27
|
Non-binding resolutions urge support for Federal legislation authorizing the importation of prescription drugs.
(SCR 27 Filed 2/10/04; adopted by Senate and House 4/30/04; certified and sent to Congress 5/10/04)
(HR 47 filed 3/15/04; adopted by House 4/7/04; certified and sent to Congress 5/14/04)
(HCR 70 adopted by House; died in Senate 5/5/04)| |
Imp |
HI
SB 3045
Sen. Hooser
|
Would authorize the state and the Hawaii Rx program to purchase prescription drugs from and negotiate manufacturer's rebates with Canadian pharmaceutical companies for the benefit of non-Medicaid eligible persons and government program beneficiaries.
(Filed 1/28/04; ; died at end of regular session 5/5/04)| |
Imp |
HI
SB 3237 |
Sen. Menor
|
Adopts income limits and other eligibility requirements for state drug prescription program, renamed Hawaii Rx Plus. Clarifies consequences of manufacturer nonparticipation. Requires rebates from participating manufacturers. Establishes committee to recommend drugs for preferred and nonpreferred drug lists.
(Filed 1/28/04; passed Senate 3/2/04; passed House 4/5/04; signed by governor as Act 47, 5/3/04) | |
D, Rebates, PDL |
ID
HJM 016
Rep. Shepard
|
Non-binding resolution, would urge Congress to adopt legislation to allow people of the United States and state and local government entities to legally purchase prescription drugs in Canada.
(Filed 2/11/04; did not pass by end of session 4/12/04) |
Imp |
ID
SB 1419
Judiciary and Rules Committee
|
Would establish the Idaho Prescription Drug Program.
(Filed 3/1/04; did not pass by end of session 4/12/04) |
D, Rebate |
IL
HB 4233
Rep. Franks
|
Would require drug companies to disclose the nature and value of any gifts, fees, payments and other economic benefits related to promotions by a pharmaceutical company to doctors and pharmacists.
(Filed and sent to committee, 1/30/04; did not pass committee 3/23/04; did not pass by end of session 12/04) |
Mkt |
IL
HB 6787
Rep. Mulligan
|
Would provide that if the State allows or provides incentives for State employees or State retirees to purchase prescription drugs from a pharmacist or other distributor located in a country other than the United States, then the Department of Public Health must develop and implement a certification program for those foreign drugs.
(Filed and sent to committee 2/9/04; did not pass by end of session 12/04) | |
Imp |
IL
HB 6851
Rep. Coulson
|
Would provide that, in the event that the current pharmacy assistance program ceases to provide benefits and the federal government creates a Medicare prescription drug benefit, the Department shall develop a new supplemental coverage program to help cover out-of- pocket expenses "including premiums, deductibles, co-payments and any other expenses required by enrollees" in the Medicare prescription drug benefit program. Provides guidelines for coverage under and eligibility for the program.
(Filed and sent to committee 2/9/04; did not pass by end of session 12/04) | |
MMA |
IL
HB 6871
|
Would establish regulation of pharmacy benefits managers by requiring: a certificate of authority from the Director of Insurance and Pharmacy Board, filing and state approval of contracts, and financial examination by the state.
(Filed and sent to committee 2/9/04; did not pass by end of session 12/04) | |
PBM |
IL
HJR 56
Rep. Franks
|
Non-binding resolution, would urge Congress to pass legislation allowing purchase of prescription drugs in Canada.
(Filed and sent to committees 2/4/04 & 5/11/04; did not pass by end of session 12/04) | |
Imp |
|
IL
SB 2253
Sen. Demuzio
|
Amends the Pharmacy Practice Act, by adding the activities of "preparation, computer entry and verification of medication orders, medical devices and prescriptions" as steps regulated under pharmaceutical dispensing.
(Passed Senate 3/25/04; passed House 5/26/04; signed by governor as Public Act 93-1075, 1/18/05) |
Lab, - |
IL
SB 2608
Sen. Obama
|
Would require the Senior Health Assistance Program Clearinghouse to provide information concerning the purchase of prescription drugs from sources outside Illinois. Also would require the governor to request the U.S. Department of Health and Human Services to license the Senior Health Assistance Program to act as an agent for Illinois senior citizens.
(Filed and sent to committees 2/27/04; did not pass by end of session 12/04) | |
Imp, CL |
IL
SB 2609
Sen. Obama
|
Would expand the definition of "mail-order pharmacy" and requirements concerning registration of mail-order pharmacies to include pharmacies located outside of the US, including Canada.
(Filed and sent to committee 2/4/04; did not pass by end of session 12/04) | |
Imp |
IN
HB 1085
Rep. Reske
|
Among other things, would establish a regional drug repository program to distribute donated drugs to nonprofit health clinics.
(Filed 1/13/04; did not pass by end of session 3/04) | |
Re |
IN
HB 1251
Rep. Becker
|
Establishes the Indiana Prescription Drug Advisory Committee, which is required to "make program design recommendations" to coordinate the Indiana drug subsidy program with the federal Medicare law... to ensure that the program does not duplicate benefits." The committee must report before July 1, 2004 for program changes related to Medicare discount program, and September 1 2004 for changes related to the part D subsidy program.
Also establishes a Regional Drug Repository Program to allow return and reuse of unused medications by pharmacists, hospitals, health care facilities or practitioners. Also expands regulation of protocols concerning the adjustment of a patient's drug regimen to nursing homes
(Filed 1/20/04; Passed House 2/5/04 and Senate 2/19/04; signed by governor as Public Law 75, 3/17/04) |
MMA, Re |
IN
HB 1265
Rep. Kersey
|
Requires the state personnel department to establish a bulk prescription drug purchasing program to negotiate terms related to the purchase of prescription drugs; requires participation by certain entities and allows participation by other certain entities; authorizes the state to enter into multi-state prescription drug bulk purchasing agreements.
(Filed 1/15/04; passed House 2/5/04; passed Senate 2/24/04; signed by governor as Public Law 50, 3/16/04) |
Bulk |
IN
HB 1363
Rep. Messer
|
Would require the board of pharmacy to establish procedures under which pharmacies may return expired drugs to drug wholesalers and manufacturers; prohibits a pharmacist from dispensing a prescription drug unless the wholesaler or manufacturer of the drug has a procedure for the return of expired drugs that complies with procedures established by the board of pharmacy.
(Filed 1/20/04; did not pass by end of session 3/04) | |
Re |
IN
HR 59
Rep. Brown
|
Would urge the health finance commission to look into generic drug pricing.
(Filed, adopted by House 3/1/04) |
Generic, Study |
|
IN
SB 73
Sen. Breaux |
Would allow a pharmacy or pharmacist to donate unused medication of a Medicaid recipient and would make provisions regarding the Regional Drug Depository Program.
(Filed 12/2/03; did not pass by end of session 3/04) | |
Re |
IN
SB 285
Sen. Ford
|
Would mandate that a prescription label must include a statement of the purpose or symptom for which the drug is prescribed if the practitioner directs that the statement is to be included; provides that a practitioner is not liable for failing to inform a patient that the patient has the option to have the purpose or symptom for which the drug is prescribed on the label.
(Filed 1/8/04; passed Senate 1/27/04; did not pass House by end of session 3/04) | |
Lab |
IN
SB 424
Sen. Dillon
|
Would require the secretary of family and social services to establish a prescription drug card program through which negotiated benefits related to the purchase of a prescription drug are available to certain residents.
(Filed 1/12/04; did not pass by end of session 3/04) | |
D |
IN
SB 497
Sen. Simpson
|
Would require the state personnel department to establish an aggregate prescription drug purchasing program to negotiate terms related to the purchase of prescription drugs; requires participation by certain entities and allows participation by certain other entities; authorizes the state to enter into multi-state prescription drug aggregate purchasing agreements; requires the budget agency to report to the budget committee on participation.
(Filed 1/13/04; passed Senate 2/4/04; did not pass by end of session 3/04) | |
Bulk |
IA
HF 2191
Rep. Murphy
|
Would establish a cancer drug repository program.
(Filed 2/9/04; ; did not pass by end of regular session 4/20/04) | |
Re |
IA
HF 2507,
HF 2216,
SF 2229
Rep. Heaton
|
Would establish a prescription drug assistance program and clearinghouse for patient assistance program information.
(Filed 2/11/04 & 3/8/04; did not pass by end of regular session 4/20/04; see HF 2554 below) | |
CL |
IA
HF 2554
Rep. Heaton
|
Establishes a prescription drug assistance clearinghouse for patient information. It requires manufacturers doing business with the state to report the details of their patient assistance programs. Requests approval for federal funding, with a conditional approriation of $250,000 if federal funds are not acquired by Oct. 1, 2004.
(Passed House 4/4/04; passed Senate 4/13/04; sent to governor; vetoed by governor as unnecessary & duplicative of federal efforts, 5/14/04)| |
CL, MMA |
IA
HSB 620
|
Would regulate the sale or distribution of prescription drugs via the Internet or electronic mail, and providing penalties.
(Filed 2/9/04 and sent to committee; did not pass by end of regular session 4/20/04) | |
Mail, Internet |
IA
HCR 119
Human Resources
|
Would establish a committee to recommend developing a drug repository program.
(Filed 3/9/04; did not pass by end of regular session 4/20/04) | |
Re |
IA
SF 2016
Sen. Johnson
|
Would establish a prescription drug assistance program by the commissioner of insurance including a contingent appropriation.
(Filed 1/21/04 and sent to committee 1/26/04; did not pass by end of regular session 4/20/04) | |
D, CL |
IA
HF 496,
SF 2283
State Gov't Comm.
|
Would regulate pharmacy benefit managers, including licensing, annual reports and a disclosure statement to PBM enrollees.
(Filed 3/8/04; did not pass by end of regular session 4/20/04) | |
PBM |
IA
SR 110
Sen. Ragan
|
Non-binding resolution would encourage the expansion of the Iowa Priority Prescription Savings Program.
(Filed 2/4/04 ; did not pass by end of regular session 4/20/04) | |
D |
KS
SB 542
Committee on Ways and Means
|
Would prohibit the use of social security numbers (SSN) on health insurance and prescription drug cards.
(Filed 2/2/04; passed Senate 3/11/04; did not pass by end of session 5/28/04) | |
- |
KY
HJR 38
Rep. Nunn
|
Would direct the Cabinet for Health Services to study the expansion of the federal 340B prescription drug discount program; including a report to Legislature by October 30, 2004
(Filed1/7/04 and sent to committee) |
340B |
KY
HCR 59
Rep. Cherry
|
Non-binding resolution would urge the U.S. Congress and the Dept for Health and Human Services to limit or ban direct to the consumer advertising of prescription drugs.
(Filed 1/8/04 and sent to committee) |
Mkt |
KY
HB 86
Rep. Burch
|
Charitable Drug Program: Require the Board of Pharmacy and Department for Public Health to jointly establish a plan for a drug repository program to accept and dispense prescription drugs donated for the purpose of being dispensed to individuals who meet eligibility standards.
(Filed 1/6/04 and sent to committee) |
Re |
KY
HB 641
Rep. Pasley
|
Would provide a tax credit for the cost of prescription drugs.
(Filed 1/27/04 and sent to committee) |
S, Tax |
KY
SS-SB 7
(Special Session) |
Would propose to establish a program to allow public employees and the Medicaid program to purchase prescription drugs from Canada, as part of reform of state employee health plan. Would request a federal waiver whre needed.
(Filed for special session of 10/7/04; did not pass by end of session) |
Imp, M |
KY
SB 180
Sen. Roeding
|
Would define "counterfeit prescription drug" and make it illegal to sell, possess, distribute or facilitate distribution of them.
(Filed and sent to committee 2/17/04) |
counter-
feit - |
KY
SB 255
Sen. Denton
|
Would allow manufacturer to distribute anticonvulsants that are controlled substances to physicians though patient assistance programs.
(Filed and sent to committee 3/2/04) |
- |
LA
HB 318
Rep. Hutter
|
Would require that the symptom or medical condition for a prescription be indicated on the label or not, if the patient desires.
(Filed 3/16/04; did not pass committee 5/26/04) |
Lab |
LA
HB 894
Rep. Dorsey
|
Creates the crime of illegal importation of prescription drugs.
(Filed 3/19/04; did not pass by end of '04 session, 6/21/04)| |
Imp. |
LA
HB 1036
Rep. Dorsey
|
Would provide for definitions and penalties for unfair and deceptive trade practices relating to the sale of certain prescription drugs.
(Filed 3/19/04; ; did not pass by end of '04 session, 6/21/04)| |
- |
LA
HB 1252
Rep. Futrell
|
Would create the Prescription Drug Advisory Commission to study access to and pricing of prescription drugs.
(Filed 3/19/04; ; did not pass by end of '04 session, 6/21/04)| |
Study |
LA
HB 1402
Rep. Walker
|
Allows for re-use of prescription drugs from returns, exchanges and donations with certain conditions. Effective date August 15, 2004.
(Filed 3/19/04; passed House and Senate; signed by governor as Act 811, 7/12/04) |
Re |
LA
SB 59
Rep. Fields
|
Proposed law would enact the Fair Market Drug Pricing Act. Would allow the secretary of DHH to negotiate discount prices or rebates for prescription drugs from drug manufacturers and labelers. Would establish the Rx Card program in accordance with federal law and allow for the secretary of DHH to adopt rules requiring disclosure of the amount of savings provided as a result of the Rx Card program.
(Filed 3/10/04; ; did not pass by end of '04 session, 6/21/04)| |
D |
ME
LD 1713/SB 645
Sen. Brennan
|
Non-binding Senate Resolve would establish a commission to study access to prescription medication for persons with mental illness.
(Filed and sent to committee 1/7/04; did not pass in committee 3/22/04)| |
M, PDL |
ME
LD 1720/SB 653
Sen. Treat |
Would "ensure the lowest-priced prescription drugs for Maine seniors."
(Filed and sent to committee 1/7/04; did not pass in committee 3/31/04)| |
D |
ME
LD 1747/HB 1269
Rep. Craven
|
Would modify the Medicaid Drug Rebate and Elderly Low-Cost Drug Program by authorizing the state to establish enrollee copayments of $2 for those in the catastrophic part of the state subsidy program.
(Filed and sent to committee 1/7/04; passed House and Senate 3/31/04; signed by governor as Chapter 611, 4/9/04)| |
S, M |
ME
LD 1811/H 1333
Rep. Dudley |
Non-binding resolve, would provide that the Department of Human Services should adopt rules for the MaineCare program to provide access to certain HIV and AIDS drugs without requiring completion of a prior authorization process.
(Filed 1/7/04; died in committee 3/2/04)| |
M, PDL |
ME
LD 1826
Sen. Bromley
|
Would "Encourage the Proper Disposal of Expired Pharmaceuticals" by return of unsused prescription drugs in a safe and secure manner by mail to a central facility. It does not provide for reuse of such drugs.
(Filed 1/7/04; unfinished; did not pass 4/1/04)| |
Re |
ME
LD 1828
Rep. Brannigan
|
FY05 budget requires a Medicare beneficiary to use the Medicare drug discount card before using a state sponsored discount program for a pharmaceutical purchase.
(Filed 1/20/04; passed House and Senate on 1/30/04; signed by governor as Chapter 513 on 1/30/04) | |
MMA |
ME
LD 1890/S 736
Sen. Treat
|
Would require that drug manufacturers doing business in the State report and certify to the Department of Human Services, for each of their drugs, the actual average wholesale price and the wholesale acquisition cost and the average manufacturer price and the best price as defined by federal law.
(Filed 2/26/04; passed House 4/14/04; passed Senate 4/15/04; signed by governor as Chapter 667 on 4/26/04)| |
M, D, price |
ME
LD1919/H 1420
Rep. Brannigan
|
FY05 Budget allocates $42.9 million funds for drug rebates in the MaineCare program "in order to properly reflect nonmatched MaineCare expenditures. "(i.e. no federal funds). Also authorizes a voluntary mail-order program for Medicaid and state-only Rx programs.
(Filed 3/16/04; passed House and Senate 4/16/04 & 4/28/04; signed by governor as Chapter 673, 4/29/04)| |
M, Mail, S |
MD
HB 116
Del. Costa
|
Would require the Maryland Health Care Commission to require that a pharmacy discount card option be included in the minimum benefits allowed to be offered in the Comprehensive Standard Health Benefit Plan offered in the small group insurance market; would establish the amount of specified co-payments and deductibles.
< | |
